|
|
english
|
español
|
français
|
Sign Up for an Account
|
Sign In
Country Profiles...
Home
The BCH
The Protocol
Finding Information
Registering Information
Resources
Help
Finding Information
National Contacts
Laws and Regulations
Country's Decisions and other Communications
Submissions
Risk Assessments
Roster of Experts
LMOs, Genes or Organisms
National Reports
Capacity-Building
Organizations
The BCH Virtual Library
Survey on indicators (2014)
Compiled Information
National Contacts
LMO Registry
Organism Registry
Gene Registry
Go to record ID
Home
|
Finding Information
|
Record details
Risk Assessment
Record information and status
Record ID
107917
Status
Published
Date of creation
2015-03-24 08:02 UTC (german_bch@bvl.bund.de)
Date of last update
2020-07-31 13:16 UTC (german_bch@bvl.bund.de)
Date of publication
2020-08-03 06:14 UTC (nina.opitz@bmel.bund.de)
Tweeter
This document is also available in the following languages:
<Select language>
English
German
General Information
Country
Germany
Title of risk assessment
6786-01-0213 (adv. 42010.0213); Summary of the risk assessment of a deliberate release (field trial) of genetically modified Rhodococcus equi RG2837, issued by the German Competent Authority
Date of the risk assessment
2012-06-04
Competent National Authority(ies) responsible for the risk assessment
Record #12096
Federal Office of Consumer Protection and Food Safety
Mauerstrasse 39-42
Berlin
Germany, 10117
Phone:
+49-(0)3018-445-6500
Fax:
+49-(0)3018-445-6099
Email:
german_bch@bvl.bund.de
Url:
http://www.biosafety-bch.de (english language)
,
BVL Homepage (English)
Risk assessment details
Living modified organism
Record #107877
Rhodococcus equi Vaccine
Intervet Resistance to diseases and pests - Bacteria
Scope of the risk assessment
LMOs for introduction into the environment
field trial
Risk assessment report / Summary
EN
6786-01-0213 (adv. 42010.0213); Summary of the risk assessment of a deliberate release (field trial) of genetically modified Rhodococcus equi RG2837, issued by the German Competent Authority (courtesy translation; only the German text is authentic)
DE
6786-01-0213 (bzw. 42010.0213); Zusammenfassung der Risikobewertung eines Freisetzungsvorhabens (Feldversuch) mit gentechnisch verändertem Rhodococcus equi RG2837, erstellt durch die deutsche zuständige Behörde
Methodology and points to consider
Potential adverse effects identified in the risk assessment
The execution of this field trial is not expected to have a negative impact on human or animal health, or on the environment.
Estimation of the overall risk
Adverse effects on human or animal health or on the environment are not expected.
Receiving environment(s) considered
One field site in Germany, for details refer to the German LMO/GMO location register (
http://apps2.bvl.bund.de/stareg_web/localeSwitch.do?language=en&page=/showflaechen.do?
)
Additional Information
Additional Information
deliberate release, no placing on the market.
animal experiment for vaccine design
publication:
Bargen and Haas (2009) Molecular and infection biology of the horse pathogen Rhodococcus equi, FEMS Microbiol Rev, 33: 870-891
Other relevant website address or attached documents
EN
BVL database on field trials in Germany (German language only)
DE
BVL-Datenbank zu Freisetzungsvorhaben in Deutschland
EN
BVL German LMO/GMO location register
DE
Deutsches GVO-Standortregister des BVL
EN
Summary Notification Information Format available on the Internet (WebSNIF)
DE
Summary Notification Information Format erhältlich im Internet (WebSNIF) (nur in englischer Sprache)
Records referencing this document
(
1
)
ID
Description
1
record(s) found
Country's Decision or any other Communication
1 record
Contact us
|
Site Map
|
Linkages Policy
|
Privacy Policy
|
Disclaimer
|
© SCBD 2001-2016
Rate this page
- 66 people have rated this page